Displaying 21 - 40 of 1706
Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
FTC Finalizes Consent Order in Boeing, Spirit Acquisition
The Boeing Co. /Spirit AeroSystems Holdings
The Federal Trade Commission will require The Boeing Company (Boeing) to divest significant Spirit AeroSystems Holdings, Inc. (Spirit) assets to resolve antitrust concerns surrounding Boeing’s $8.3 billion acquisition of Spirit.
On February 17, 2026, the FTC finalized the consent order in this matter.
Express Scripts, Inc., et al.; Analysis of Agreement Containing Consent Order To Aid Public Comment
Sevita and BrightSpring; Analysis of Proposed Agreement Containing Consent Orders To Aid Public Comment
XCL Resources Holdings, LLC et al, USA v.
The Federal Trade Commission announced that crude oil producers XCL Resources Holdings, LLC (XCL), Verdun Oil Company II LLC (Verdun), and EP Energy LLC (EP) will pay a record $5.6 million civil penalty to settle allegations they engaged in illegal pre-merger coordination, known as gun jumping, in violation of the Hart-Scott-Rodino Act (HSR Act).
FTC Takes Action to Prevent Anticompetitive Healthcare Services Merger
FTC Announces 2026 Update of Jurisdictional and Fee Thresholds for Premerger Notification Filings
Edwards Lifesciences Corporation and JenaValve Technology, Inc., FTC v.
Statement on FTC Victory Halting Anticompetitive Medical Device Deal
FTC Sues to Stop Loctite, Liquid Nails Construction Adhesive Merger
FTC Bureau of Competition Statement on Termination of Healthcare Managed Services Merger
FTC Requires Boeing to Divest Several Spirit Assets to Proceed with Merger
Valvoline and Greenbriar; Analysis of Agreement Containing Consent Orders to Aid Public Comment
GTCR BC Holdings, LLC and Surmodics, Inc., In the Matter of
The Federal Trade Commission issued an administrative complaint to challenge GTCR BC Holdings, LLC’s acquisition of Surmodics, Inc., alleging that the deal, which seeks to combine the two largest manufacturers of critical medical device coatings, is anticompetitive. The FTC charges that private equity firm GTCR’s proposed acquisition of Surmodics would create a combined company controlling more than 50% of the market for outsourced hydrophilic coatings. These coatings are often used by medical device manufacturers and are applied to lifesaving medical devices such as catheters and guidewires.
The Federal Trade Commission filed an amended complaint adding the states of Illinois and Minnesota as co-plaintiffs in the Commission’s lawsuit challenging GTCR BC Holdings, LLC’s (GTCR) acquisition of Surmodics, Inc. (Surmodics). The amended complaint also adds GTCR, LLC as an additional defendant in the case.
FTC Approves Final Consent Order in ACT-Giant Eagle Deal
Displaying 21 - 40 of 1706